The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical pharmacology and therapy

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0009-9236(96)90055-7PMID 8841151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis

  2004cited by this paper
• High-performance liquid chromatographic method for the quantitative determination of butorphanol, hydroxybutorphanol, and norbutorphanol in human urine using fluorescence detection.

  1994cited by this paper
• The effects of age and sex on the systemic

  1994cited by this paper
• The effect of hepatic disease on the disposition of moricizine in humans

  1994cited by this paper
• Multiple‐dose phase I study of transnasal butorphanol

  1993cited by this paper
• Buffer conditions affecting the separation of Maillard reaction products by capillary electrophoresis

  1993cited by this paper
• Quantifying Hepatic Function in the Presence of Liver Disease with Phenazone (Antipyrine) and its Metabolites

  1991cited by this paper
• Rank Transformations as a Bridge between Parametric and Nonparametric Statistics

  1981cited by this paper
• Serum levels of butorphanol by radioimmunoassay.

  1980cited by this paper
• Disposition of parenteral butorphanol in man.

  1980cited by this paper
• The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time

  1980cited by this paper
• Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease—a hypothesis

  1979cited by this paper
• The Effect of Disease States on Drug Pharmacokinetics

  1977cited by this paper
• The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease

  1976cited by this paper
• Propranolol Disposition in Chronic Liver Disease: A Physiological Approach

  1976cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper
• Determinants of serum antipyrine half-lives in patients with liver disease

  1973cited by this paper
• An Analysis of Transformations

  1964cited by this paper

• Effectiveness of Butorphanol in alleviating intra- and post-operative visceral pain following microwave ablation for hepatic tumor: a dual-central, randomized, controlled trial

  2024cites this paper
• A Short History of the Discovery and Development of Naltrexone and Other Morphine Derivatives

  2014cites this paper
• Evaluation of the Allometric Exponents in Prediction of Human Drug Clearance

  2014cites this paper
• Analgesic efficacy of tramadol and butorphanol in mandibular third molar surgery: a comparative study.

  2012cites this paper
• Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.

  2012cites this paper
• Efeitos da dexmedetomidina administrada em infusão intravenosa contínua, associada ou não ao butorfanol, em equinos

  2010cites this paper
• Opioid rotation: the science and the limitations of the equianalgesic dose table.

  2009cites this paper
• Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus).

  2008cites this paper
• A practical guide for clinicians

  2007cites this paper
• Bioavailability of intranasal butorphanol administered from a single-dose sprayer.

  2005cites this paper
• Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.

  2004cites this paper
• Nasal administration of opioids for pain management in adults

  2002cites this paper
• Pharmacokinetics and selected behavioral responses to butorphanol and its metabolites in goats following intravenous and intramuscular administration.

  2001cites this paper
• Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine

  2000cites this paper
• Pharmacokinetic Interaction Between Butorphanol Nasal Spray and Oral Metoclopramide in Healthy Women

  1997cites this paper